Skip to main content
Healthcare

STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more

STAT+: Pharmalittle: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more

Feed excerpt — reported by STAT News

Missouri attorney general warned Eli Lilly to discontinue requiring hospitals to provide claims data to receive discounted medicines under 340B program

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.